1.1

NBA Organisation as at 30 June 2020

2.1

Returns to Government 2015-16 to 2019-20

2.2

Red cells issued by Lifeblood 2015-16 to 2019-20 per '000 population

2.3

Platelets issued by Lifeblood 2015-16 to 2019-20 per '000 population

2.4

Whole blood and apheresis plasma for fractionation 2015-16 to 2019-20

2.5

Plasma derived and overseas product expenditure: cumulative increases on 2003-04 base year

2.6

Issues of Factor VIII products 2015-16 to 2019-20 per '000 population

2.7

Issues of Factor IX products 2015-16 to 2019-20 per '000 population

2.8

Issues of Factor VIIa products 2015-16 to 2019-20 per '000 population

2.9

Issues of FEIBA, 2015-16 to 2019-20 per '000 population

2.10

Issues of Immunoglobulin products, 2015-16 to 2019-20 per '000 population

3.1

Governance and Authority in the Blood Sector

3.2

Governance and Authority in the NBA

3.3

NBA Planning Framework

3.4

NBA Organisational Chart